Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
Study NCT ID:
NCT07047560
Status:
RECRUITING
Last Update Posted:
2025-07-02
First Post:
2025-06-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-24
First Submit QC Date:
None
Study First Post Date:
2025-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-24
Last Update Post Date:
2025-07-02
Last Update Post Date Type:
ACTUAL